Rheumatoid arthritis and periodontal disease

Joint Bone Spine

Volumn 77, Issue 6, 2010, Pages 537-541

  Berthelot, Jean Marie ^a   Le Goff, Benoît ^a  

^a HÔTEL DIEU   (France)

Author keywords

Citrullination; Periodontitis; Periodontium; Porphyromonas gingivalis; RANK Ligand; Rheumatoid arthritis

Indexed keywords

ANTIGEN; AUTOANTIGEN; CITRULLINE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DNA; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERLEUKIN 17; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADAPTIVE IMMUNITY; ANTIBODY TITER; ATHEROMA; B LYMPHOCYTE; BACTERIUM; BIOLOGICAL THERAPY; CLINICAL TRIAL; COHORT ANALYSIS; CYTOMEGALOVIRUS; DENTAL CARE; DENTAL SURGERY; DISEASE ASSOCIATION; DISEASE SEVERITY; EPSTEIN BARR VIRUS; GENE OVEREXPRESSION; GINGIVA; GINGIVITIS; HERPES VIRUS; HISTOPATHOLOGY; HUMAN; INNATE IMMUNITY; NONHUMAN; OSTEOLYSIS; PATHOGENESIS; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTITIS; PLASMA CELL; PORPHYROMONAS GINGIVALIS; PREVALENCE; RHEUMATOID ARTHRITIS; RISK FACTOR; SHORT SURVEY; SJOEGREN SYNDROME; SMOKING; SYNOVIUM; T LYMPHOCYTE;

ARTHRITIS, RHEUMATOID; BONE RESORPTION; COMORBIDITY; GENETIC PREDISPOSITION TO DISEASE; GINGIVA; HLA-DR ANTIGENS; HUMANS; PEPTIDES, CYCLIC; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RANK LIGAND;

EID: 78649907653     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.04.015     Document Type: Short Survey

References (60)

1. Pischon N., Pischon T., Kröger J., et al. Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol 2008, 79:979-986.
2. Smolik I., Robinson D., El-Gabalawy H.S. Periodontitis and rheumatoid arthritis: epidemiologic, clinical, and immunologic associations. Compend Contin Educ Dent 2009, 30:188-190.
3. Helenius L.M., Meurman J.H., Helenius I., et al. Oral and salivary parameters in patients with rheumatic diseases. Acta Odontol Scand 2005, 63:284-293.
4. Craig R.G., Boylan R., Yip J., et al. Serum IgG antibody response to periodontal pathogens in minority populations: relationship to periodontal disease status and progression. J Periodontal Res 2002, 37:132-146.
5. Hamevose-Poulsen A., Sorensen L.K., Stoltze K., et al. Cytokine profiles in peripheral blood and whole blood cell cultures associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. J Periodontol 2005, 76:2276-2285.
6. De Pablo P., Dietrich T., McAlindon T.E. Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J Rheumatol 2008, 35:70-76.
7. Mercado F.B., Marshall R.I., Klestov A.C., et al. Relationship between rheumatoid arthritis and periodontitis. J Periodontol 2001, 72:779-787.
8. Marotte H., Farge P., Gaudin P., et al. The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction. Ann Rheum Dis 2006, 65:905-909.
9. Stein J., Reichert S., Gautsch A., et al. Are there HLA combinations typical supporting for or making resistant against aggressive and/or chronic periodontitis?. J Periondotal Res 2003, 38:508-517.
10. Pers J.O., d'Arbonneau F., Devauchelle-Pensec V., et al. Is periodontal disease mediated by salivary BAFF in Sjögren's syndrome?. Arthritis Rheum 2005, 52:2411-2414.
11. Kuru B., McCullough M.J., Yilmaz S., et al. Clinical and microbiological studies of periodontal disease in Sjogren syndrome patients. J Clin Periodontol 2002, 29:92-102.
12. Berglundh T., Donati M. Aspects of adaptive host response in periodontitis. J Clin Periodontol 2005, 32(Suppl. 6):87-107.
13. Gamonal J., Acevedo A., Bascones A., et al. Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 2000, 71:1535-1545.
14. Cutler C.W., Jotwani R., Palucka K.A., et al. Evidence and a novel hypothesis for the role of dendritic cells and Porphyromonas gingivalis in adult periodontitis. J Periodontal Res 1999, 34:406-412.
15. Nakajima T., Ueki-Maruyama K., Oda T., et al. Regulatory T-cells infiltrate periodontal disease tissues. J Dent Res 2005, 84:639-643.
16. Zitzmann N.U., Berglundh T., Lindhe J. Inflammatory lesions in the gingiva following resective/non-resective periodontal therapy. J Clin Periodontol 2005, 32:139-146.
17. Moshref M., Mashhadi-Abbass F., Sargolzaei S., et al. Extramedullary plasmocytoma of the gingiva. Arch Iran Med 2007, 10:91-93.
18. Kinane D.F., Lappin D.F., Koulouri O., et al. Humoral immune responses in periodontal disease may have mucosal and systemic immune features. Clin Exp Immunol 1999, 115:534-541.
19. Nakajima T., Amanuma R., Ueki-Maruyama J., et al. CXCL13 expression and follicular dendritic cells in relation to B-cell infiltration in periodontal disease tissues. J Periodontal Res 2008, 43:635-641.
20. Harada Y., Han X., Yamashita K., et al. Effect of adoptive transfer of antigen-specific B cells on periodontal bone resorption. J Periodontal Res 2006, 41:101-107.
21. Gemmell E., Carter C.L., Hart D.N., et al. Antigen-presenting cells in human periodontal disease tissues. Oral Microbiol Immunol 2002, 17:388-393.
22. Berglundh T., Donati M., Zitzmann N. B cells in periodontitis: friends or enemies?. Periodontol 2007, 45:51-66.
23. Faizuddin M., Bharathi S.H., Rohini N.V. Estimation of interleukin-1beta levels in the gingival crevicular fluid in health and in inflammatory periodontal disease. J Periodontal Res 2003, 38:111-114.
24. Biyikoglu B., Buduneli N., Kardesler L., et al. Evaluation of t-PA, PAI-2, IL-1beta andpgE(2) in gingival crevicular fluid of rheumatoid arthritis patients with periodontal disease. J Clin Periodontol 2006, 33:605-611.
25. Kobayashi T., Ito S., Kuroda T., et al. The interleukin-1 and Fcgamma receptor gene polymorphisms in Japanese patients with rheumatoid arthritis and periodontitis. J Periodontol 2007, 78:2311-2318.
26. Vernal R., Dutzan N., Chaparro A., et al. Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol 2005, 32:383-389.
27. Yu J.J., Ruddy M.J., Wong G.C., et al. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 2007, 109:3794-3802.
28. Bostanci N., Ilgenli T., Emingil G., et al. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J Clin Periodontol 2007, 34:367-369.
29. Kawai T., Matsuyama T., Hosokawa Y., et al. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol 2006, 169:987-998.
30. Lu H.K., Chen Y.L., Chang H.C., et al. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. J Peridontol Res 2006, 41:354-360.
31. Bostanci N., Ilgenli T., Emingil G., et al. Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases. J Periodontol Res 2007, 42:287-293.
32. Taubman M.A., Valverde P., Han X., et al. Immune response: the key to bone resorption in periodontal disease. J Periodontol 2005, 76(Suppl. 11):2033-2041.
33. Han X., Kawai T., Eastcott J.W., et al. Bacterial-responsive B lymphocytes induce periodontal bone resorption. J Immunol 2006, 176:625-631.
34. Colucci S., Mori G., Brunetti G., et al. Interleukin-7 production by B lymphocytes affects the T cell-dependent osteoclast formation in an in vitro model derived from human periodontitis patients. Int J Immunopathol Pharmacol 2005, 18(Suppl. 3):13-19.
35. Wara-aswapati N., Surarit R., Chayasadom A., et al. RANKL upregulation associated with periodontitis and Porphyromonas gingivalis. J Periodontol 2007, 78:1062-1069.
36. Belibasakis G.N., Bostanci N., Hashim A., et al. Regulation of RANKL and OPG gene expression in human gingival fibroblasts and periodontal ligament cells by Porphyromonas gingivalis: a putative role of the Arg-gingipains. Microb Pathog 2007, 43:46-53.
37. Vis M., Havaardsholm E.A., Haugeberg G., et al. Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis 2006, 65:1495-1499.
38. Pers J.O., Saraux A., Pierre R., et al. Anti-TNF-alpha immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis. J Periodontol 2008, 79:1645-1651.
39. Garlet G.P., Cardoso C.R., Silva T.A., et al. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol 2006, 21:12-20.
40. Van Winkelhoff A.J., Bosch-Tijhof C.J., Winkel E.G., et al. Smoking affects the subgingival microflora in periodontitis. J Periodontol 2001, 72:666-671.
41. Contreras A., Umeda M., Chen C., et al. Relationship between herpes viruses and adult periodontitis and periodontopathic bacteria. J Periodontol 1999, 70:478-484.
42. Slots J., Kamma J.J., Sugar C. The herpes virus-Porphyromonas gingivalis-periodontitis axis. J Periodontal Res 2003, 38:318-323.
43. Kubar A., Saygun I., Ozdemir A., et al. Real-time polymerase chain reaction quantification of human cytomegalovirus and Epstein-Barr virus in periodontal pockets and the adjacent gingiva of periodontitis lesions. J Periodontal Res 2005, 40:97-104.
44. Van Winkelhoff A.J., Loos B.G., van der Reijden W.A., et al. Porphyromonas gingivalis, Bacteroides forsythus and other putative periodontal pathogens in subjects with and without periodontal destruction. J Clin Periodontol 2002, 29:1023-1028.
45. Rams T.E., Listgarten M.A., Slots J. Utility of 5 major putative periodontal pathogens and selected clinical parameters to predict periodontal breakdown on maintenance care. J Clin Peridontol 1996, 23:346-354.
46. Furuichi Y., Shimotsu A., Ito H., et al. Associations of periodontal status with general health conditions and serum antibody titers for Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans. J Periodontol 2003, 74:1491-1497.
47. Moen K., Brun J.G., Madland T.M., et al. Immunoglobulin G and A antibody responses to Bacteroides forsythus and Prevotella intermedia in sera and synovial fluids of arthritis patients. Clin Diagn Lab Immunol 2003, 10:1043-1050.
48. Rams T.E., Listgarten M.A., Slots J. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis subgingival presence, species-specific serum immunoglobulin G antibody levels, and periodontitis disease recurrence. J Peridontal Res 2006, 41:228-234.
49. Martinez-Martinez R.E., Abud-Mendoza C., Patino-Marin N., et al. Detection of periodontal bacterial DNA in serum and synovial fluid in refractory rheumatoid arthritis patients. J Clin Periodontol 2009, 36:1004-1010.
50. Moen K., Brun J.G., Valen M., et al. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs. Clin Exp Rheumatol 2006, 24:656-663.
51. Rosenstein E.D., Greenwald R.A., Kushner L.J., et al. Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation 2004, 28:311-318.
52. Hamevose-Poulsen A., Westergaard J., Stoltze K., et al. Periodontal and hematological characteristics associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. J Periodontol 2006, 77:280-288.
53. Molitor J.A., Alonso A., Wener M.H., et al. Moderate to severe adult periodontitis increases risk of rheumatoid arthritis in non-smokers and is associated with elevated ACPA titers: the ARIC study. Arthritis Rheum 2009, 60(Suppl. 10):S433.
54. Nesse W., Westra J., van der Wal J.E., et al. The periodontium contains citrullinated proteins, PAD-2 enzymes and HC Gp-39. Arthritis Rheum 2009, 60(Suppl. 10):S434-S435.
55. Soory M. Periodontal diseases and rheumatoid arthritis: a coincident model for therapeutic intervention?. Curr Drug Metab 2007, 8:750-757.
56. Berthelot J.M., Le Goff B., Maugars Y. Thymic Hassall's corpuscles, regulatory T cells, and rheumatoid arthritis. Semin Arthritis Rheum 2010, 39:347-355.
57. Al-Katma M.K., Bissada N.F., Bordeaux J.M., et al. Control of periodontal infection reduces the severity of active rheumatoid arthritis. J Clin Rheumatol 2007, 13:134-137.
58. Ortiz P., Bissada N.F., Palomo L., et al. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol 2009, 80:535-540.
59. Abou-Raya S., Abou-Raya A., Naim A., et al. Rheumatoid arthritis, periodontal disease and coronary artery disease. Clin Rheumatol 2008, 27:421-427.
60. Mayer Y., Balbir-Gurman A., Machtei E.E. Anti-tumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis. J Periodontol 2009, 80:1414-1420.